Pamela Berry

4.5k total citations · 1 hit paper
27 papers, 3.2k citations indexed

About

Pamela Berry is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Pamela Berry has authored 27 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Pamela Berry's work include Systemic Lupus Erythematosus Research (13 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Pamela Berry is often cited by papers focused on Systemic Lupus Erythematosus Research (13 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Pamela Berry collaborates with scholars based in United States, United Kingdom and Canada. Pamela Berry's co-authors include Gale Harding, Ingela Wiklund, Paul Jones, Nancy Kline Leidy, Maggie Tabberer, Ren Yu, Sonya Eremenco, Pratik P. Pandharipande, Ayumi Shintani and Frances Barr and has published in prestigious journals such as CHEST Journal, Critical Care Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

Pamela Berry

27 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development and first validation of the COPD Assessment Test

2009 2.3k citations Paul Jones, Gale Harding et al. European Respiratory Journal profile →

Peers

Countries citing papers authored by Pamela Berry

Since Specialization

Citations

This map shows the geographic impact of Pamela Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Berry more than expected).

Fields of papers citing papers by Pamela Berry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Berry. The network helps show where Pamela Berry may publish in the future.

Co-authorship network of co-authors of Pamela Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Berry. A scholar is included among the top collaborators of Pamela Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Berry. Pamela Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patient-reported outcomes and healthcare resource utilization in systemic lupus erythematosus: impact of disease activity 2024 ·BMC Rheumatology ·Zahi Touma, Karen H. Costenbader, (unknown), (unknown), David R. Bell, James Pike, Pamela Berry, Chetan S. Karyekar	2
2	Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus 2022 ·Annals of the Rheumatic Diseases ·Ronald van Vollenhoven, Kenneth Kalunian, Thomas Dörner, Bevra H. Hahn, Yoshiya Tanaka, Robert Gordon, (unknown), Kaiyin Fei, Sheng Gao, Loqmane Seridi, Patrick G. Gallagher, Kim Hung Lo, Pamela Berry, Qing Zuraw	46
3	A qualitative exploration of the patient experience of erosive and non-erosive hand osteoarthritis 2021 ·Journal of Patient-Reported Outcomes ·Charlotte Panter, Pamela Berry, (unknown), (unknown), (unknown), (unknown), (unknown), Rob Arbuckle	9
4	Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study 2021 ·The Journal of Rheumatology ·Ronald van Vollenhoven, Bevra H. Hahn, George C. Tsokos, Peter E. Lipsky, Robert Gordon, Kaiyin Fei, Kim Hung Lo, Marc Chévrier, Shawn Rose, Pamela Berry, Zhenling Yao, Chetan S. Karyekar, Qing Zuraw	22
5	Systemic Lupus Erythematosus Symptom Clusters and Their Association With Patient‐Reported Outcomes and Treatment: Analysis of Real‐World Data 2020 ·Arthritis Care & Research ·Zahi Touma, (unknown), (unknown), David R. Bell, (unknown), Jennifer H. Lofland, Pamela Berry, Chetan S. Karyekar, Karen H. Costenbader	11
6	Long‐Term Impact of Belimumab on Health‐Related Quality of Life and Fatigue in Patients With Systemic Lupus Erythematosus: Six Years of Treatment 2018 ·Arthritis Care & Research ·Vibeke Strand, Pamela Berry, Xiwu Lin, Yumi Asukai, (unknown), Sulabha Ramachandran	35
7	Literature review to assemble the evidence for response scales used in patient-reported outcome measures 2018 ·Journal of Patient-Reported Outcomes ·Katharine S. Gries, Pamela Berry, Magdalena Harrington, Mabel Crescioni, (unknown), K. Rüdell, Shima Safikhani, (unknown), Margaret Vernon	45
8	Patient-Reported Outcome (PRO) Consortium translation process: consensus development of updated best practices 2018 ·Journal of Patient-Reported Outcomes ·Sonya Eremenco, (unknown), (unknown), Pamela Berry	68
9	Patient experience in systemic lupus erythematosus: development of novel patient-reported symptom and patient-reported impact measures 2018 ·Journal of Patient-Reported Outcomes ·Susan D. Mathias, Pamela Berry, JE de Vries, (unknown), Hilary H. Colwell, David J. Chang, Anca Askanase	9
10	Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia 2018 ·Angiogenesis ·Marie E. Faughnan, James R. Gossage, Murali M. Chakinala, S. Paul Oh, Raj S. Kasthuri, Christopher C.W. Hughes, Justin P. McWilliams, Joseph G. Parambil, Nicholas T. Vozoris, Jill Donaldson, Gitanjali Paul, Pamela Berry, Dennis L. Sprecher	74
11	Using a ResearchKit Smartphone App to Collect Rheumatoid Arthritis Symptoms From Real-World Participants: Feasibility Study 2018 ·JMIR mhealth and uhealth ·Michelle Crouthamel, Emilia Quattrocchi, (unknown), (unknown), Pamela Berry, Luis Garcia‐Gancedo, Valentin Hamy, Rachel E. Williams	58
12	Patient Evaluation of Satisfaction and Outcomes with an Autoinjector for Self-Administration of Subcutaneous Belimumab in Patients with Systemic Lupus Erythematosus 2017 ·Patient ·(unknown), Gale Harding, (unknown), (unknown), Pamela Berry, Sulabha Ramachandran	31
13	Treatment Satisfaction in Systemic Lupus Erythematosus 2017 ·JCR Journal of Clinical Rheumatology ·Susan D. Mathias, Pamela Berry, (unknown), (unknown), Anca Askanase, Hilary H. Colwell, David J. Chang	7
14	AB0421 Evaluation of The Experience, Satisfaction and Outcomes of An Autoinjector for Self-Administration of Subcutaneous Belimumab in Patients with Systemic Lupus Erythematosus (SLE) 2016 ·Annals of the Rheumatic Diseases ·(unknown), G Harding, (unknown), (unknown), Pamela Berry, (unknown)	1
15	653 2013 ·Critical Care Medicine ·Heidi Smith, (unknown), Jenna Sopfe, Daniel Fishman, Pamela Berry, (unknown), E. Wesley Ely, Pratik P. Pandharipande	1
16	Development of the Shortness of Breath with Daily Activities Questionnaire (SOBDA) 2012 ·Value in Health ·Kellee Howard, Pamela Berry, Jennifer Petrillo, Ingela Wiklund, Laurie Roberts, Michael L. Watkins, Courtney Crim, Teresa K. Wilcox	15
17	Tests of the Responsiveness of the COPD Assessment Test Following Acute Exacerbation and Pulmonary Rehabilitation 2012 ·CHEST Journal ·Paul Jones, Gale Harding, Ingela Wiklund, Pamela Berry, Maggie Tabberer, Ren Yu, Nancy Kline Leidy	127
18	Diagnosing delirium in critically ill children: Validity and reliability of the Pediatric Confusion Assessment Method for the Intensive Care Unit* 2010 ·Critical Care Medicine ·Heidi A. B. Smith, Jenny Boyd, D. Catherine Fuchs, Kelly Melvin, Pamela Berry, Ayumi Shintani, Svetlana Eden, (unknown), (unknown), (unknown), Jenna Sopfe, Frances Barr, Pratik P. Pandharipande, E. Wesley Ely	212
19	Development and first validation of the COPD Assessment Test breakdown → 2009 ·European Respiratory Journal ·Paul Jones, Gale Harding, Pamela Berry, Ingela Wiklund, (unknown), Nancy Kline Leidy	2262
20	Improving the process and outcome of care in COPD: development of a standardised assessment tool 2009 ·Primary Care Respiratory Journal ·Paul Jones, Gale Harding, Ingela Wiklund, Pamela Berry, Nancy Kline Leidy	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact